Search results
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 15 hours agoThis trial evaluated the efficacy of AbbVie/Roche's Venclexta (venetoclax) and BeiGene's Brukinsa...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 4 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Érik Canuel, director of Bon Cop, Bad Cop and other Quebec hit films, has died at 63
CBC via Yahoo News· 14 hours agoHe was 63 years old. Annexe, a Montreal-based communications firm, confirmed Canuel's death on...
EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe introduction of the first-generation BCR-ABL1 tyrosine kinase inhibitor (TKI), Novartis's...
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
The West Side Index & Gustine Press-Standard· 4 days ago- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, including those receiving prior venetoclax
The Valley’s Jason Caperna Dragged Into Lala Kent’s Feud With Brittany Cartwright
Reality Tea via Yahoo News· 5 days agoPhoto Credit: Paul Archuleta/Getty Images for The Leukemia and Lymphoma Society There’s a lot more...
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Zacks via Yahoo Finance· 18 hours agoAmgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month...
Modern death cafes are very much alive in L.A. Inside the radical movement
LA Times via AOL· 6 days agoUnderwood died unexpectedly in 2017 due to complications from leukemia, but the movement he...
For some Maine families, upcoming increase to TANF benefits could be a lifeline
Maine Morning Star via Yahoo News· 22 hours agoFive years ago, McLaughlin’s son, Leon, was diagnosed with leukemia. He finished treatment two years...
A Bixby teen is the face of the St. Jude Dream Home Giveaway Campaign nationwide
FOX23 News· 15 hours agoA Bixby Teen is the face of the St. Jude Dream Home Giveaway Campaign not just in Tulsa, but all...
